Related Experiment Video
Updated: Mar 6, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
HIF2 drives PTHrP-mediated cancer cachexia.
Jiaxin Yan1, Wenhui Wang1, Gaofei Wei1
1Laboratory of Cellular Metabolism and Precision Therapeutics, School of Life Science and Technology, Northwestern Polytechnical University, Xi'an 710072, China; Research & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen 518057, China.
Hypoxia-inducible factor 2 (HIF2) inhibition effectively treats cachexia and hypercalcemia in renal cancer. This approach targets parathyroid hormone-related protein (PTHrP), reversing metabolic wasting and normalizing calcium levels.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Advanced renal cancer often presents with cachexia and hypercalcemia.
- These conditions are typically viewed as secondary to tumor burden.
Purpose of the Study:
- To investigate the potential of hypoxia-inducible factor 2 (HIF2) inhibition in managing cachexia and hypercalcemia associated with renal cancer.
- To re-evaluate the nature of these paraneoplastic syndromes.
Main Methods:
- Pharmacologic inhibition of HIF2.
- Assessment of parathyroid hormone-related protein (PTHrP) levels.
- Evaluation of metabolic wasting and calcium levels.
Main Results:
- HIF2 inhibition rapidly suppressed PTHrP.
- Metabolic wasting was reversed.
- Calcium levels were normalized.
Conclusions:
- Paraneoplastic cachexia and hypercalcemia in renal cancer can be effectively targeted by HIF2 inhibition.
- These syndromes may be reclassified as targetable endocrine disorders.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
PI3K/mTOR/AKT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
The Intrinsic Apoptotic Pathway
TGF - β Signaling Pathway

